Clinical trial
Warfarin and Antiplatelet Therapy in Chronic Heart Failure
NCT00007683 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00007683 |
|---|---|
| Title | Warfarin and Antiplatelet Therapy in Chronic Heart Failure |
| Official title | CSP #442 - Warfarin and Antiplatelet Therapy Study in Patients With Congestive Heart Failure (WATCH) |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Collaborators | Sanofi-Synthelabo Industry Bristol-Myers Squibb |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Drug |
| Interventions | Warfarin titrated to an INR of 2.5-3.0, Aspirin, Clopidogrel 75 |
| Enrollment | 1,587 |
| Start date | Oct 1, 1998 |
| Primary completion | Jul 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Jan 1, 2001 |
| Last update posted | Jun 16, 2011 |
| Countries | Canada, United Kingdom, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: